PRIME MEDICINE, INC. (PRME)
Prime Medicine Announces New Zealand Clearance of Clinical Trial Application for PM577a in H1069Q-mutated Wilson Disease
Prime Medicine Announces New Zealand Clearance of Clinical Trial Application for PM577a in H1069Q-mutated Wilson Disease
Bionano Announces 67% Year-Over-Year Growth in Studies Featuring Optical Genome Mapping at ESHG 2026, Reflecting Expanding Global Adoption
Aterian, Inc. Announces Mailing of Proxy Materials for Special Meeting of Stockholders
CROSS TIMBERS ROYALTY TRUST DECLARES JUNE CASH DISTRIBUTION
RoboStrategy, Inc. Raises Approximately $28.9 Million Through Private Share Issuances
Proof Over Promises: UPSs Bold AI Initiatives Enhance Products, Services and Customer Experience
Perion Launches Ask Perion, an Agentic Self-Serve Mobile App Designed to Accelerate Omnichannel Execution and Increase Efficiency
ZenaTech Unveils Zoo Office™, an AI-Powered Enterprise Productivity Platform Positioned to Capitalize on the Rapidly Growing Agentic AI Market
Kraft Heinz Announces New Global Operating Structure to Accelerate Growth
Denali Therapeutics Enters Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $195 Million